HCLTech launches advanced clinical trials solution with Denodo and AWS

TAGS

HCLTech, a prominent global technology company, has unveiled a cutting-edge clinical trials and diagnosis solution developed in collaboration with Denodo, a leader in data management, and Amazon Web Services (AWS). This groundbreaking solution is set to revolutionise the pace of diagnosis and treatment research, enhancing the efficiency and effectiveness of clinical trials.

Advanced solution to accelerate clinical trials and diagnosis

The new clinical trials and diagnosis solution leverages the Denodo Platform, a sophisticated data integration and management tool hosted on the AWS Cloud. HCLTech has integrated this platform to create robust data assets that seamlessly fit into customers’ data analytics frameworks, facilitating modernised reporting and in-depth analysis. The solution promises to significantly improve the capture and utilisation of comprehensive data insights from clinical studies.

Streamlined data management for better decision-making

This innovative solution aims to streamline clinical trials by enabling pharmaceutical companies to efficiently compare new treatments against established ones. It considers various dosages and demographic impacts through a centralised data model that ensures secure, real-time access to critical data. The integration of Denodo’s platform helps in navigating the complexities of clinical trials, managing diverse data sources, and adhering to stringent regulations.

See also  HCLTech unveils digital solutions in three sectors on Salesforce platform

Expert opinions on the collaboration

Ananth Subramanya, Executive Vice President of Digital Business Services at HCLTech, commented that the solution harnesses the power of logical data management to provide a consolidated view of clinical study data. This data is easily accessible to both patients and healthcare professionals, enhancing healthcare data analytics and modernising data management practices.

Suresh Chandrasekaran, Executive Vice President at Denodo, expressed excitement about the partnership, highlighting Denodo’s ability to integrate disparate data sources. This integration creates semantic data products related to drugs, patients, and providers, delivering them as on-demand services to HCLTech applications. Chandrasekaran noted that this approach reduces time to value and cost, while improving governance and overall efficiency.

See also  A new era in banking: Boardwalktech and HCLTech's secret weapon against regulatory fines

A transformative approach to data management

HCLTech’s new solution, developed in collaboration with Denodo and AWS, represents a significant advancement in clinical trials and diagnosis. By integrating sophisticated data management tools with AWS’s cloud solutions, the partnership is set to enhance the capabilities of pharmaceutical companies and healthcare providers. The innovative approach promises to streamline operations, accelerate research, and ultimately improve patient outcomes through better data insights and decision-making.


What is the goal of the new clinical trials solution by HCLTech, Denodo, and AWS?

The solution aims to accelerate medical research by improving the capture, analysis, and utilization of data, thus speeding up the pace of diagnosis and development of new treatments.

See also  Gamuda Berhad expands collaboration with Google Cloud to elevate gen AI capabilities across workforce

How does the collaboration between HCLTech, Denodo, and AWS enhance clinical trials?

By integrating Denodo’s data management platform with AWS Cloud, the solution provides a robust framework for managing complex data sets, enabling faster comparative analysis of treatments and streamlined regulatory compliance.

What are the benefits of the new clinical trials solution for healthcare providers?

Healthcare providers can benefit from enhanced data analytics, better decision-making capabilities, and reduced time to value for clinical research, ultimately leading to more effective treatment options for patients.


Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.

CATEGORIES
TAGS
Share This